The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme -a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone
Scientific summary Background
Although breast screening with mammography is recognised as the most effective method of detecting early-stage breast cancer and reducing breast cancer mortality, up to 30% of cancers are not detected by standard screening and this percentage is higher in dense breasts and in women under 50 years of age. A major limitation of breast screening mammography is that overlapping fibroglandular tissue can decrease the visibility of abnormalities or mimic abnormalities. As a result, some cancers are missed and there are unnecessary recalls, assessments and psychological stress.
Women with increased breast density have an increased risk of developing breast cancer, have lower screening programme sensitivity, and tend to have larger screen-detected and interval cancers. This is of concern for the NHS Breast Screening Programme (NHSBSP) as it extends the programme screening to include younger women and to offer screening mammography to women with a family history (FH) of breast cancer.
Digital breast tomosynthesis (DBT) is a newly developed three-dimensional (3D) imaging technique that has the potential to improve the accuracy of mammography by reducing interference from breast tissue overlap. This facilitates differentiation between malignant and non-malignant features and could decrease the number of false-positive recalls, associated health-care costs and patient anxiety.
The optimal role for DBT in the diagnosis and assessment of breast cancer is still uncertain. Current evidence indicates that DBT should be used as an adjunct to two-dimensional (2D) mammography. However, the additional radiation exposure required to obtain a standard 2D mammogram could be avoided if a synthetic 2D mammogram could be reconstructed from the images acquired from DBT imaging.
Objectives
l To compare the diagnostic accuracy of using DBT in conjunction with 2D or synthetic 2D, against standard 2D mammography in a retrospective reading study. l To determine if the use of DBT in conjunction with 2D or synthetic 2D improves the accuracy of detection of (1) small or subtle breast cancers, (2) cancers in women with dense breasts, (3) cancers presenting as soft-tissue masses and (4) cancers presenting as microcalcifications. l To assess the performance of two automated breast density software programs against observer-based visually assessed breast density. l To assess the association of breast density with cancer incidence.
Study population
The study was conducted in six UK NHSBSP centres. Women (aged 47-73 years) recalled for further assessment after routine breast screening and women (aged 40-49 years) with moderate/high of risk of developing breast cancer who were attending annual mammography screening were recruited into the trial after giving written informed consent.
Intervention
All participants underwent standard two-view [mediolateral oblique (MLO) and craniocaudal (CC)] 2D mammography of both breasts and two-view (MLO and CC) DBT imaging acquired in a single examination under the same degree of breast compression. Image-processing software generated a synthetic 2D mammogram from the acquired 3D images.
Retrospective reading study
In an independent retrospective reading study, readers reviewed (1) 2D, (2) 2D + DBT or (3) synthetic 2D + DBT images for a case without access to original screening mammograms or prior examinations, and readers were blinded to the outcome status of each case.
Sensitivities and specificities were calculated for each of the three reading arms, for all cases combined, and then for subgroups by visually assessed breast density and dominant radiological feature. In addition, sensitivity to cancers was calculated for subgroups by lesion size [invasive and ductal carcinoma in situ (DCIS) separately] and histological grade. Sensitivity and specificity were compared between reading arms using McNemar methods, and receiver operating characteristic (ROC) analysis was performed to compare the diagnostic accuracy of the three reading arms (2D alone vs. 2D + DBT vs. synthetic 2D + DBT) by calculating the area under the curve and p-values.
Results
A total of 8869 participants were recruited over a 21-month period. This data set comprised 7684 cases recruited sequentially from assessment clinics and 1185 cases from women aged 40-49 years at moderate/ high risk of developing breast cancer (subsequently referred to as FH cases). The latter group provided a cohort with higher breast density for subanalysis of the impact of breast density on the diagnostic accuracy of DBT.
After exclusions, there were 7060 subjects for analysis comprising 6020 (1158 cancers) assessment cases and 1040 (two cancers) FH cases. Reading data were available for 6928 (98%) cases by 2D only, 6960 (99%) by 2D + DBT and 6654 (94%) by synthetic 2D + DBT. The analysis included cases read in only two arms of the study to avoid introducing bias and was repeated using only cases which were read in all three arms. This produced identical results.
For all subjects combined, sensitivity was 87% [95% confidence interval (CI) 85% to 89%] for 2D only, 89% (95% CI 87% to 91%) for 2D + DBT and 88% (95% CI 86% to 90%) for synthetic 2D + DBT. The difference in sensitivity between 2D and 2D + DBT was of borderline significance (p = 0.07) and for synthetic 2D + DBT there was no significant difference (p = 0.6). Sensitivity was significantly higher for 2D + DBT than for 2D alone for invasive tumours of size 11-20 mm, for women with breast density of 50% or more (p = 0.03), and for age range 50-59 years (p = 0.01). A similar increase in sensitivity (p = 0.01) was seen for 2D + DBT in grade 2 invasive tumours (but not grade 1 or grade 3), and for lesions in which the dominant radiological feature was a mass (p = 0.04). For synthetic 2D + DBT, there was significantly (p = 0.006) higher sensitivity than for 2D alone in invasive cancers of size 11-20 mm. Cancers missed by 2D alone tended to be of size 11-20 mm, or to have a mass as the major radiological sign, compared with the other two reading modalities; cancers missed by 2D + DBT were less likely than the other two reading modalities to be of grade 2 or to have density less than 50%. The borderline improvement in cancer detection in the DBT reading arms compared with 2D alone differs from recent prospective screening studies, but this may be as a result of differences in case selection and study design.
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NIHR Journals Library www.journalslibrary.nihr.ac.uk iv Specificity was 58% (95% CI 56% to 60%) for 2D, 69% (95% CI 67% to 71%) for 2D + DBT and 71% (95% CI 69% to 73%) for synthetic 2D + DBT. Specificity was significantly higher for 2D + DBT and for DBT + synthetic 2D than for 2D (p < 0.001 in both cases). With ROC analysis, a significant increase in diagnostic accuracy (p < 0.001) for 2D + DBT and synthetic 2D + DBT compared with 2D alone was observed, most likely as a result of the marked improvement in specificity. The increases in specificity for the DBT reading arms were observed in all subgroups of breast density and dominant radiological feature and across all age groups (p < 0.001 in all cases). In all three reading arms, specificity tended to be lower for microcalcifications and higher for distortion/asymmetry, and synthetic 2D + DBT was inferior to both 2D and 2D + DBT in the detection of microcalcifications and DCIS of size 11-20 mm.
The breast density substudy evaluating the performance of two automated breast density software programs against observer-based visually assessed breast density indicated a high degree of variation in density as scored by readers, whereas the two commercially available software packages appeared to provide a more reliable assessment. The results confirmed the strong relationship between volumetric density and increased risk of breast cancer that has already been reported but highlighted the need for further research in this area to develop an accurate and reproducible method of breast density measurement for the assessment of breast cancer risk.
Conclusions
This reading study showed that the performance of 2D with DBT was better than 2D alone in terms of specificity, with a marginal improvement in sensitivity, and that synthetic 2D was comparable to conventional 2D when used with DBT. Case selection bias in the study design limits extrapolation of the results to a screening population. However, the observation that integrated 2D + DBT imaging was equally effective across all age groups and breast densities (and in particular for women aged 50-59 years and for breast density ≥ 50%) could be advantageous to the planned age extension of the NHSBSP and to screening mammography of the younger cohort of FH women. In addition, the potential to reduce false-positive recalls could also benefit both screening programmes and the screening population. However, further research is required to evaluate the practicalities and costs of implementing 2D + DBT in a screening setting and to undertake further comparison with 2D and synthetic 2D for different lesion types and breast densities. Prognostic modelling on existing data sets could be used to predict the impact on outcomes and mortality. Validated measures of breast density are required to assess personalised breast cancer risk and screening recommendations. In addition, the performance of DBT systems from different manufacturers needs to be evaluated.
Study registration
This trial is registered as ISRCTN73467396.
